Literature DB >> 1867245

Sleep apnea and systemic hypertension: a causal association review.

V Hoffstein1, C K Chan, A S Slutsky.   

Abstract

OBJECTIVE: To critically examine the causal association between sleep apnea syndrome and hypertension.
METHODS: A retrospective systematic critique of five epidemiologic studies published in the English literature during 1978 to 1989 identified on Medline and manual literature searches. The evidence was evaluated using the standard observational criteria for causation: strength of association, consistency, dose-response relationship, temporal sequence, specificity, and biologic plausibility.
RESULTS: We found evidence to support a causal association between sleep apnea syndrome and hypertension in consistency and specificity and some evidence to suggest a dose-response relationship. Review of the data dealing with the mechanisms important in the pathogenesis of sleep apnea and hypertension allowed us to advance several theories to provide support for biologic plausibility.
CONCLUSION: We concluded that there is a positive association--relative risk estimate between 1.3 and 40--for sleep apnea syndrome and hypertension, but the risk association is unstable. Thus, we believe that there is insufficient data to justify doing polysomnography as part of the routine diagnostic work-up for patients with hypertension.

Entities:  

Mesh:

Year:  1991        PMID: 1867245     DOI: 10.1016/0002-9343(91)90014-o

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management.

Authors:  Stephen K Williams; Joseph Ravenell; Girardin Jean-Louis; Ferdinand Zizi; James A Underberg; Samy I McFarlane; Gbenga Ogedegbe
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  Relationship between Duration of Sleep and Hypertension in Adults: A Meta-Analysis.

Authors:  Yan Wang; Hao Mei; Yan-Rui Jiang; Wan-Qi Sun; Yuan-Jin Song; Shi-Jian Liu; Fan Jiang
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

Review 3.  Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components.

Authors:  Girardin Jean-Louis; Ferdinand Zizi; Luther T Clark; Clinton D Brown; Samy I McFarlane
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

4.  [Guidelines for home oxygen and home ventilation therapy. German Society of Pneumology, German Society of Sleep Medicine, Working Group of Nocturnal Respiratory and Cardiovascular Disorders, Working Circle of Home and Long-Term Ventilation].

Authors:  D Köhler; C P Criée; F Raschke
Journal:  Med Klin (Munich)       Date:  1997-01-15

5.  Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study.

Authors:  P Lavie; P Herer; V Hoffstein
Journal:  BMJ       Date:  2000-02-19

6.  Knowledge of sleep apnea in a sample grouping of primary care physicians.

Authors:  S A Chung; S Jairam; M R Hussain; C M Shapiro
Journal:  Sleep Breath       Date:  2001-09       Impact factor: 2.816

7.  Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome.

Authors:  P Cortelli; P Parchi; E Sforza; M Contin; G Pierangeli; G Barletta; E Lugaresi
Journal:  Clin Auton Res       Date:  1994-04       Impact factor: 4.435

8.  Hypopnea in pediatric patients with obesity hypertension.

Authors:  Erin Parrish Reade; Craig Whaley; Jen-Jar Lin; Daniel W McKenney; Daniel Lee; Ronald Perkin
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

9.  Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters.

Authors:  A Gambineri; C Pelusi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

10.  Sleep apnoea in patients with quadriplegia.

Authors:  R D McEvoy; I Mykytyn; D Sajkov; H Flavell; R Marshall; R Antic; A T Thornton
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.